A randomised controlled trial of vaporised Δ


Journal

European archives of psychiatry and clinical neuroscience
ISSN: 1433-8491
Titre abrégé: Eur Arch Psychiatry Clin Neurosci
Pays: Germany
ID NLM: 9103030

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 13 12 2018
accepted: 03 01 2019
pubmed: 21 1 2019
medline: 6 6 2019
entrez: 21 1 2019
Statut: ppublish

Résumé

Access to cannabis and cannabinoid products is increasing worldwide for recreational and medicinal use. Two primary compounds within cannabis plant matter, Δ

Identifiants

pubmed: 30661105
doi: 10.1007/s00406-019-00978-2
pii: 10.1007/s00406-019-00978-2
doi:

Substances chimiques

Cannabinoid Receptor Modulators 0
Cannabidiol 19GBJ60SN5
Dronabinol 7J8897W37S

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

17-35

Subventions

Organisme : National Health and Medical Research Council
ID : 1007593
Organisme : Australian Research Council
ID : FT110100752

Références

J Pharmacol Exp Ther. 2000 Mar;292(3):960-7
pubmed: 10688610
Psychol Med. 2002 Feb;32(2):347-58
pubmed: 11866327
Clin Pharmacokinet. 2003;42(4):327-60
pubmed: 12648025
Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
Neuropsychopharmacology. 2004 Aug;29(8):1558-72
pubmed: 15173844
Med Hypotheses. 2006;66(2):234-46
pubmed: 16209908
Naunyn Schmiedebergs Arch Pharmacol. 2006 Feb;372(5):354-61
pubmed: 16489449
Psychopharmacology (Berl). 2006 Jun;186(2):226-34
pubmed: 16572263
Psychopathology. 2006;39(4):175-8
pubmed: 16636640
J Pharm Sci. 2006 Jun;95(6):1308-17
pubmed: 16637053
Lancet. 2007 Jul 28;370(9584):319-28
pubmed: 17662880
Br J Pharmacol. 2008 Jan;153(2):199-215
pubmed: 17828291
Brain Res. 2008 Jan 10;1188:157-64
pubmed: 18021759
Schizophr Bull. 1991;17(4):555-64
pubmed: 1805349
J Forensic Sci. 2008 Jan;53(1):90-4
pubmed: 18279244
Br J Psychiatry. 2008 Apr;192(4):306-7
pubmed: 18378995
Schizophr Res. 2008 Aug;103(1-3):138-42
pubmed: 18387788
J Psychopharmacol. 2008 Sep;22(7):707-16
pubmed: 18515447
Psychol Med. 2009 Oct;39(10):1607-16
pubmed: 19335936
Pharmacol Biochem Behav. 2009 Aug;93(2):91-6
pubmed: 19393686
Psychopharmacology (Berl). 1990;100(4):558-9
pubmed: 1969666
Prog Neuropsychopharmacol Biol Psychiatry. 2009 Nov 13;33(8):1517-21
pubmed: 19735690
Neuropsychopharmacology. 2010 Feb;35(3):764-74
pubmed: 19924114
Neuropsychopharmacology. 2010 Aug;35(9):1879-85
pubmed: 20428110
Br J Psychiatry. 2010 Oct;197(4):285-90
pubmed: 20884951
Drug Alcohol Depend. 2011 Apr 1;114(2-3):242-5
pubmed: 21050680
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jan 15;35(1):198-202
pubmed: 21062637
Schizophr Res. 2011 Aug;130(1-3):216-21
pubmed: 21592732
Psychopharmacology (Berl). 2011 Nov;218(2):443-57
pubmed: 21667074
Psychopharmacology (Berl). 2012 Jan;219(1):247-9
pubmed: 21947314
Curr Pharm Des. 2012;18(32):5113-30
pubmed: 22716133
Annu Rev Psychol. 2013;64:21-47
pubmed: 22804774
Transl Psychiatry. 2012 Mar 20;2:e94
pubmed: 22832859
J Psychopharmacol. 2013 Jan;27(1):19-27
pubmed: 23042808
Mol Pharmacol. 2013 Feb;83(2):322-38
pubmed: 23160940
Br J Pharmacol. 2013 Dec;170(7):1365-73
pubmed: 23550724
PLoS One. 2013 Jul 24;8(7):e70052
pubmed: 23894589
Br J Pharmacol. 2013 Dec;170(7):1363-4
pubmed: 24024867
J Neurosci. 2014 Sep 24;34(39):13096-109
pubmed: 25253856
Br J Pharmacol. 2015 Feb;172(3):737-53
pubmed: 25257544
BMC Pharmacol Toxicol. 2014 Oct 16;15:58
pubmed: 25319497
Neuropsychopharmacology. 2015 May;40(6):1436-47
pubmed: 25510937
Eur Neuropsychopharmacol. 2015 Mar;25(3):325-34
pubmed: 25534187
FASEB J. 2015 Apr;29(4):1446-55
pubmed: 25550466
Br J Pharmacol. 2015 Oct;172(20):4790-805
pubmed: 26218440
Addiction. 2015 Dec;110(12):1941-50
pubmed: 26234170
Lancet Psychiatry. 2015 Mar;2(3):233-8
pubmed: 26359901
Br J Pharmacol. 2016 Jan;173(1):53-65
pubmed: 26377899
Transl Psychiatry. 2016 Jan 12;6:e710
pubmed: 26756903
Biol Psychiatry. 2016 Apr 1;79(7):e17-31
pubmed: 26858212
Biol Psychiatry. 2016 Apr 1;79(7):557-67
pubmed: 26858214
Biol Psychiatry. 2016 Apr 1;79(7):613-9
pubmed: 26903403
Neurosci Biobehav Rev. 2017 May;76(Pt B):380-395
pubmed: 27639448
Neurosci Biobehav Rev. 2017 Jan;72:310-324
pubmed: 27884751
Eur Neuropsychopharmacol. 2017 Feb;27(2):132-145
pubmed: 28043732
Lancet Psychiatry. 2017 Aug;4(8):643-648
pubmed: 28259650
Front Pharmacol. 2017 May 11;8:259
pubmed: 28553229
Cannabis Cannabinoid Res. 2017 Sep 01;2(1):235-246
pubmed: 29098186
Eur Neuropsychopharmacol. 2017 Dec;27(12):1223-1237
pubmed: 29129557
Am J Psychiatry. 2018 Mar 1;175(3):225-231
pubmed: 29241357
Cannabis Cannabinoid Res. 2018 Mar 01;3(1):21-34
pubmed: 29607408
Mol Pharmacol. 2018 Jul;94(1):743-748
pubmed: 29669714
Cannabis Cannabinoid Res. 2018 Apr 01;3(1):94-107
pubmed: 29682609
Br J Pharmacol. 2019 May;176(10):1455-1469
pubmed: 29981240
Transl Psychiatry. 2018 Sep 5;8(1):181
pubmed: 30185793
Front Immunol. 2018 Sep 21;9:2009
pubmed: 30298064
Braz J Psychiatry. 2019 Jan-Mar;41(1):9-14
pubmed: 30328956
CNS Drugs. 2018 Nov;32(11):1053-1067
pubmed: 30374683
JAMA Netw Open. 2018 Nov 2;1(7):e184838
pubmed: 30646385
JAMA Netw Open. 2018 Nov 2;1(7):e184841
pubmed: 30646391
Psychopharmacologia. 1973 Oct 23;33(1):53-70
pubmed: 4358666
Br J Pharmacol. 1972 Jun;45(2):375-7
pubmed: 5048656
Arch Int Pharmacodyn Ther. 1984 May;269(1):12-9
pubmed: 6087750
Psychopharmacology (Berl). 1982;76(3):245-50
pubmed: 6285406
Braz J Med Biol Res. 1983 Jul;16(2):141-6
pubmed: 6317104
Drug Metab Dispos. 1995 Aug;23(8):825-31
pubmed: 7493549
Clin Pharmacol Ther. 1976 Mar;19(3):300-9
pubmed: 770048
Addiction. 1995 May;90(5):607-14
pubmed: 7795497
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
Biol Pharm Bull. 1996 Aug;19(8):1109-11
pubmed: 8874830
Anesthesiology. 1998 Jan;88(1):82-8
pubmed: 9447860
J Trauma Stress. 1998 Jan;11(1):125-36
pubmed: 9479681
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538

Auteurs

Nadia Solowij (N)

School of Psychology and Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, Australia. nadia@uow.edu.au.
The Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), New Lambton Heights, NSW, Australia. nadia@uow.edu.au.

Samantha Broyd (S)

School of Psychology and Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, Australia.

Lisa-Marie Greenwood (LM)

School of Psychology and Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, Australia.

Hendrika van Hell (H)

School of Psychology and Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, Australia.

Dave Martelozzo (D)

School of Psychology and Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, Australia.

Kuna Rueb (K)

School of Psychology and Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, Australia.

Juanita Todd (J)

School of Psychology, University of Newcastle, University Drive, Callaghan, NSW, Australia.

Zheng Liu (Z)

School of Medicine and Public Health, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia.
Clinical Pharmacology, Department of Medicine, The Royal Children's Hospital, Melbourne, VIC, Australia.

Peter Galettis (P)

The Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), New Lambton Heights, NSW, Australia.
School of Medicine and Public Health, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia.

Jennifer Martin (J)

The Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), New Lambton Heights, NSW, Australia.
School of Medicine and Public Health, Hunter Medical Research Institute, University of Newcastle, New Lambton Heights, NSW, Australia.

Robin Murray (R)

Institute of Psychiatry, Kings College London, London, UK.

Alison Jones (A)

Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW, Australia.

Patricia T Michie (PT)

School of Psychology, University of Newcastle, University Drive, Callaghan, NSW, Australia.

Rodney Croft (R)

School of Psychology and Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH